Hargreaves Lansdown orders staff back to office August 9, 2026 The UK’s largest DIY investment site is ordering employees back to the office from the start of next year. Hargreaves Lansdown will order its staff into the workplace for three days a week, shortly after the firm moves into its new Bristol office. The wealth manager, which was acquired by buyout firms including CVC Capital [...]
Targa Newfoundland Unveils Full Sponsor Ecosystem, Announces Lives Showcase at IBC 2026 Amsterdam August 7, 2026 Dejero, ADLINK Technology, Eutelsat and Intel among the sponsors powering the first-ever livestream of North America's only tarmac rally, with a live demonstration at IBC and a video message from professional racing driver Randy Pobst.
Government urged to refuse £1bn British Steel repayment to Chinese former owner August 7, 2026 Business secretary Jonathan Reynolds has been urged to refuse to pay back almost £1bn in loans to the Chinese former owners of British Steel after it was nationalised earlier this year. British Steel owed just under £1bn to companies connected to its owner Jingye Steel before it was taken into public ownership in an emergency [...]
Norwegian FA chief Klaveness cools Fifa election talk and takes swipe at Blatter August 7, 2026 Norwegian football chief Lise Klaveness has played down her Fifa presidency ambitions and taken a swipe at Sepp Blatter, the former boss of the embattled governing body. Klaveness, a former international player, is a long-standing and outspoken critic of Fifa and has been touted as a potential challenger to current kingpin Gianni Infantino. Infantino is [...]
Algoma Central Corporation Reports Financial Results for the 2026 Second Quarter August 7, 2026 Strategic acquisitions, expanded credit facilities, and strong segment performance position Algoma for continued growth.
Battery Ventures Promotes Brandon Gleklen to Partner August 7, 2026 Gleklen, who invests in AI-application companies, joins new principal Jason Mendel and eight other investors globally promoted to new roles
Sia Accelerates Its Expansion in Australia with the Acquisition of Seven Consulting August 7, 2026 Sia continues its international expansion with the acquisition of Seven Consulting, an Australian management consulting firm known for its expertise in Business Transformation, serving many of the country’s largest Banking, Government, Transportation & Postal, Retail & Consumer Goods, and Energy & Utilities organisations. Founded in 2002, Seven Consulting brings together a team of over 100 [...]
Allianz Delivers Record Result and Is Well on Track to Achieve Its Targets August 7, 2026 2Q 2026 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806509750/en/ Total business volume at 45.6 billion euros, an internal growth of 5.7 percent1, with contributions from all segments. Asset Management delivers excellent growth. Operating profit rises 10.6 percent to a record level of 4.9 billion euros. Shareholders’ core net income at 2.6 [...]
Britain’s problem isn’t too much Thatcherism, but too little August 7, 2026 Margaret Thatcher remains a bogeyman for Andy Burnham and the British left despite having left Downing Street 35 years ago, but their critiques are wide of the mark, says Emma Revell Everyone has someone or something they blame when things get tough. Astrology girlies use the position of Mercury to absolve themselves of any responsibility [...]
Prothena Reports Second Quarter 2026 Financial Results and Business Highlights August 6, 2026 Net cash used in operating and investing activities was $25.7 million in the second quarter and net cash provided by operating and investing activities was $3.2 million for the first six months of 2026; quarter-end cash and restricted cash position was $289.1 million Guidance updated to include shares repurchased through July 30, 2026 and now expects to end the year with approximately $259 million (midpoint) in cash, cash equivalents and restricted cash Results from partner Roche evaluating prasinezumab in patients with early Parkinson’s disease from the Phase 2b PADOVA clinical trial published in The Lancet Multiple research collaborations with industry partners ongoing to explore the potential of our CYTOPE® technology over the next 12 to 24 months